DrugPatentWatch Database Preview
Chartwell Molecular Company Profile
What is the competitive landscape for CHARTWELL MOLECULAR, and what generic and branded alternatives to CHARTWELL MOLECULAR drugs are available?
CHARTWELL MOLECULAR has eight approved drugs.
Summary for Chartwell Molecular
| US Patents: | 0 |
| Tradenames: | 8 |
| Ingredients: | 8 |
| NDAs: | 8 |
Drugs and US Patents for Chartwell Molecular
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecular | RAMIPRIL | ramipril | CAPSULE;ORAL | 078745-003 | Jun 18, 2008 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Chartwell Molecular | IRBESARTAN | irbesartan | TABLET;ORAL | 077205-001 | Nov 14, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Chartwell Molecular | IRBESARTAN | irbesartan | TABLET;ORAL | 077205-003 | Nov 14, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Chartwell Molecular | RISPERIDONE | risperidone | TABLET;ORAL | 077543-002 | May 18, 2011 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Chartwell Molecular | RISPERIDONE | risperidone | TABLET;ORAL | 077543-006 | May 18, 2011 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Chartwell Molecular | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET;ORAL | 077044-001 | Nov 5, 2004 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
